BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 28433762)

  • 21. Biological basis for functional cure of chronic hepatitis B.
    Martinez MG; Testoni B; Zoulim F
    J Viral Hepat; 2019 Jul; 26(7):786-794. PubMed ID: 30803126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for the treatment of HBV/HDV.
    Krause A; Haberkorn U; Mier W
    Eur J Pharmacol; 2018 Aug; 833():379-391. PubMed ID: 29935174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B Virus Infection and Liver Decompensation.
    Luvisa BK; Hassanein TI
    Clin Liver Dis; 2016 Nov; 20(4):681-692. PubMed ID: 27742007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B Virus Cure: Targets and Future Therapies.
    Lee HW; Lee JS; Ahn SH
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging pipeline drugs for hepatitis B infection.
    Cox N; Tillmann H
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):713-29. PubMed ID: 22195605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
    Pei Y; Wang C; Yan SF; Liu G
    J Med Chem; 2017 Aug; 60(15):6461-6479. PubMed ID: 28383274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
    Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
    Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors.
    Zhang BY; Chai DP; Wu YH; Qiu LP; Zhang YY; Ye ZH; Yu XP
    Curr Drug Targets; 2019; 20(16):1636-1651. PubMed ID: 31362671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for the Global Elimination of Hepatitis B.
    Block TM; Chang KM; Guo JT
    Annu Rev Virol; 2021 Sep; 8(1):437-458. PubMed ID: 34586871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.
    Yang D; Zuo C; Wang X; Meng X; Xue B; Liu N; Yu R; Qin Y; Gao Y; Wang Q; Hu J; Wang L; Zhou Z; Liu B; Tan D; Guan Y; Zhu H
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1264-73. PubMed ID: 24616513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent Advances in Hepatitis B Virus Antivirals].
    Liu Q; Yao C; Guo X; Hu K
    Bing Du Xue Bao; 2016 Sep; 32(5):650-8. PubMed ID: 30004193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of HBV therapy.
    Pessoa MG; Wright TL
    Adv Exp Med Biol; 1999; 458():1-10. PubMed ID: 10549374
    [No Abstract]   [Full Text] [Related]  

  • 35. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in antivirals against hepatitis B virus.
    Wang YJ; Yang L; Zuo JP
    Virus Res; 2016 Feb; 213():205-213. PubMed ID: 26732483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs for hepatitis B.
    Zoulim F
    Expert Opin Emerg Drugs; 2007 May; 12(2):199-217. PubMed ID: 17604497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 39. HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals.
    Glebe D; Goldmann N; Lauber C; Seitz S
    Antiviral Res; 2021 Feb; 186():104973. PubMed ID: 33166575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.